Thor Medical ASA (OSL:TRMED)

Norway flag Norway · Delayed Price · Currency is NOK
4.685
+0.055 (1.19%)
At close: Mar 13, 2026
Market Cap1.69B +115.4%
Revenue (ttm)100.00K
Net Income-58.91M
EPS-0.22
Shares Out361.38M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume2,606,847
Average Volume3,136,798
Open4.630
Previous Close4.630
Day's Range4.510 - 4.700
52-Week Range1.942 - 5.490
Beta-0.22
RSI53.98
Earnings DateFeb 26, 2026

About Thor Medical ASA

Thor Medical ASA produces and supplies alpha-particle emitters for cancer therapy in Norway. It develops Ra224, an isotope of radium; Pb-212, a radioactive isotope of lead; and Th-228, a radioactive isotope of thorium. The company was incorporated in 2009 and is headquartered in Oslo, Norway. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2009
Employees 13
Stock Exchange Oslo Børs
Ticker Symbol TRMED
Full Company Profile

Financial Performance

Financial Statements